These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17517649)

  • 1. Broadly neutralizing anti-hepatitis B virus antibody reveals a complementarity determining region H3 lid-opening mechanism.
    Chi SW; Maeng CY; Kim SJ; Oh MS; Ryu CJ; Kim SJ; Han KH; Hong HJ; Ryu SE
    Proc Natl Acad Sci U S A; 2007 May; 104(22):9230-5. PubMed ID: 17517649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced humanization and affinity maturation of neutralizing anti-hepatitis B virus preS1 antibody based on antigen-antibody complex structure.
    Kim JH; Gripon P; Bouezzedine F; Jeong MS; Chi SW; Ryu SE; Hong HJ
    FEBS Lett; 2015 Jan; 589(2):193-200. PubMed ID: 25481411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site.
    Julien JP; Bryson S; Nieva JL; Pai EF
    J Mol Biol; 2008 Dec; 384(2):377-92. PubMed ID: 18824005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broadly neutralizing anti-HBV antibody binds to non-epitope regions of preS1.
    Chi SW; Kim J; Yi GS; Hong HJ; Ryu SE
    FEBS Lett; 2009 Sep; 583(18):3095-100. PubMed ID: 19716826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope mapping of anti-interleukin-13 neutralizing antibody CNTO607.
    Teplyakov A; Obmolova G; Wu SJ; Luo J; Kang J; O'Neil K; Gilliland GL
    J Mol Biol; 2009 May; 389(1):115-23. PubMed ID: 19361524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework.
    Hanf KJ; Arndt JW; Chen LL; Jarpe M; Boriack-Sjodin PA; Li Y; van Vlijmen HW; Pepinsky RB; Simon KJ; Lugovskoy A
    Methods; 2014 Jan; 65(1):68-76. PubMed ID: 23816785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen.
    Kucinskaite-Kodze I; Pleckaityte M; Bremer CM; Seiz PL; Zilnyte M; Bulavaite A; Mickiene G; Zvirblis G; Sasnauskas K; Glebe D; Zvirbliene A
    Virus Res; 2016 Jan; 211():209-21. PubMed ID: 26541316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs.
    Prabakaran P; Gan J; Wu YQ; Zhang MY; Dimitrov DS; Ji X
    J Mol Biol; 2006 Mar; 357(1):82-99. PubMed ID: 16426633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a humanized antibody to hepatitis B surface antigen by specificity-determining residues (SDR)-grafting and de-immunization.
    Kim KS; Kim HJ; Han BW; Myung PK; Hong HJ
    Biochem Biophys Res Commun; 2010 May; 396(2):231-7. PubMed ID: 20399745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity maturation of an anti-hepatitis B virus PreS1 humanized antibody by phage display.
    Yang GH; Yoon SO; Jang MH; Hong HJ
    J Microbiol; 2007 Dec; 45(6):528-33. PubMed ID: 18176536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of anti-HIV type 1 antibody 2F5 with phospholipid bilayers and its relevance for the mechanism of virus neutralization.
    Maeso R; Huarte N; Julien JP; Kunert R; Pai EF; Nieva JL
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):863-76. PubMed ID: 21142698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a high-affinity human antibody with a disulfide bridge in the third complementarity-determining region of the heavy chain.
    Almagro JC; Raghunathan G; Beil E; Janecki DJ; Chen Q; Dinh T; LaCombe A; Connor J; Ware M; Kim PH; Swanson RV; Fransson J
    J Mol Recognit; 2012 Mar; 25(3):125-35. PubMed ID: 22407976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for antigen recognition by methylated lysine-specific antibodies.
    Ishii M; Nakakido M; Caaveiro JMM; Kuroda D; Okumura CJ; Maruyama T; Entzminger K; Tsumoto K
    J Biol Chem; 2021; 296():100176. PubMed ID: 33303630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
    J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humanized antibody neutralizing 2009 pandemic H1N1 virus.
    Shembekar N; Mallajosyula VV; Chaudhary P; Upadhyay V; Varadarajan R; Gupta SK
    Biotechnol J; 2014 Dec; 9(12):1594-603. PubMed ID: 25044602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the Fab fragment from F124, a monoclonal antibody specific for hepatitis B surface antigen.
    Saul FA; Vulliez-Le Normand B; Passafiume M; Riottot MM; Bentley GA
    Acta Crystallogr D Biol Crystallogr; 2000 Aug; 56(Pt 8):945-51. PubMed ID: 10944330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight.
    Covaceuszach S; Cattaneo A; Lamba D
    Proteins; 2005 Feb; 58(3):717-27. PubMed ID: 15625712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a remote mutation from the contact paratope on the structure of CDR-H3 in the anti-HIV neutralizing antibody PG16.
    Kondo HX; Kiribayashi R; Kuroda D; Kohda J; Kugimiya A; Nakano Y; Tsumoto K; Takano Y
    Sci Rep; 2019 Dec; 9(1):19840. PubMed ID: 31882602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design.
    Saphire EO; Parren PW; Pantophlet R; Zwick MB; Morris GM; Rudd PM; Dwek RA; Stanfield RL; Burton DR; Wilson IA
    Science; 2001 Aug; 293(5532):1155-9. PubMed ID: 11498595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope recognition by diverse antibodies suggests conformational convergence in an antibody response.
    Nair DT; Singh K; Siddiqui Z; Nayak BP; Rao KV; Salunke DM
    J Immunol; 2002 Mar; 168(5):2371-82. PubMed ID: 11859128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.